Reports

Industry Research Reports

description

Part 1

description

Part 2

description

Part 3

description

Part 4

description

Part 5

Home > Reports > Medical Devices & Consumables > Cardiovascular POCT- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Cardiovascular POCT- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Cardiovascular POCT- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Medical Devices & Consumables

Published: 2025-02-14

Pages: 117 Pages

Report ld: 3869362

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

Description

The global market for Cardiovascular POCT was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Cardiovascular POCT, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Cardiovascular POCT by region & country, by Type, and by Application.

The Cardiovascular POCT market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiovascular POCT.

Market Segmentation

  • Report Metric

  • Details

  • Report Title

  • Cardiovascular POCT- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

  • Market Size Available for Years

  • 2025-2031

  • Global Cardiovascular POCT Companies Covered

  • Roche

    Abbott

    BioMerieux

    Wuhan Easy Diagnosis Biomedicine Co.,ltd.

    Guangzhou Wondfo Biotech Co.,Ltd.

    Getein Biotech, Inc.

    Sinocare Inc

    Relia Bioengineering Co., Ltd

    Beijing Hotgen Biotech Co.,ltd.

    Assure Tech (Hangzhou) Co.,Ltd.

    Nanjing Vazyme Biotech Co.,Ltd.

    Siemens Healthineers

    Danaher

    Sansure Biotech Inc.

  • Global Cardiovascular POCT Market, by Region

  • North America (U.S., Canada, Mexico)

    Europe (Germany, France, UK, Italy, etc.)

    Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

    South America (Brazil, etc.)

    Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

  • Global Cardiovascular POCT Market, Segment by Type

  • Based on Immunochromatography

    Based on Chemiluminescence Technology

    Based on Biosensor

    Based on Colloidal Gold

    Others

  • Global Cardiovascular POCT Market, Segment by Application

  • Hospital

    lndependent Testing Organization

  • Forecast Units

  • Million USD

  • Report Coverage

  • Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Cardiovascular POCT manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Cardiovascular POCT in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Cardiovascular POCT in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

1 Market Overview
    1.1 Cardiovascular POCT Product Introduction
    1.2 Global Cardiovascular POCT Market Size Forecast
        1.2.1 Global Cardiovascular POCT Sales Value (2020-2031)
        1.2.2 Global Cardiovascular POCT Sales Volume (2020-2031)
        1.2.3 Global Cardiovascular POCT Sales Price (2020-2031)
    1.3 Cardiovascular POCT Market Trends & Drivers
        1.3.1 Cardiovascular POCT Industry Trends
        1.3.2 Cardiovascular POCT Market Drivers & Opportunity
        1.3.3 Cardiovascular POCT Market Challenges
        1.3.4 Cardiovascular POCT Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered
2 Competitive Analysis by Company
    2.1 Global Cardiovascular POCT Players Revenue Ranking (2024)
    2.2 Global Cardiovascular POCT Revenue by Company (2020-2025)
    2.3 Global Cardiovascular POCT Players Sales Volume Ranking (2024)
    2.4 Global Cardiovascular POCT Sales Volume by Company Players (2020-2025)
    2.5 Global Cardiovascular POCT Average Price by Company (2020-2025)
    2.6 Key Manufacturers Cardiovascular POCT Manufacturing Base and Headquarters
    2.7 Key Manufacturers Cardiovascular POCT Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Cardiovascular POCT
    2.9 Cardiovascular POCT Market Competitive Analysis
        2.9.1 Cardiovascular POCT Market Concentration Rate (2020-2025)
        2.9.2 Global 5 and 10 Largest Manufacturers by Cardiovascular POCT Revenue in 2024
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiovascular POCT as of 2024)
    2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Based on Immunochromatography
        3.1.2 Based on Chemiluminescence Technology
        3.1.3 Based on Biosensor
        3.1.4 Based on Colloidal Gold
        3.1.5 Others
    3.2 Global Cardiovascular POCT Sales Value by Type
        3.2.1 Global Cardiovascular POCT Sales Value by Type (2020 VS 2024 VS 2031)
        3.2.2 Global Cardiovascular POCT Sales Value, by Type (2020-2031)
        3.2.3 Global Cardiovascular POCT Sales Value, by Type (%) (2020-2031)
    3.3 Global Cardiovascular POCT Sales Volume by Type
        3.3.1 Global Cardiovascular POCT Sales Volume by Type (2020 VS 2024 VS 2031)
        3.3.2 Global Cardiovascular POCT Sales Volume, by Type (2020-2031)
        3.3.3 Global Cardiovascular POCT Sales Volume, by Type (%) (2020-2031)
    3.4 Global Cardiovascular POCT Average Price by Type (2020-2031)
4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospital
        4.1.2 lndependent Testing Organization
    4.2 Global Cardiovascular POCT Sales Value by Application
        4.2.1 Global Cardiovascular POCT Sales Value by Application (2020 VS 2024 VS 2031)
        4.2.2 Global Cardiovascular POCT Sales Value, by Application (2020-2031)
        4.2.3 Global Cardiovascular POCT Sales Value, by Application (%) (2020-2031)
    4.3 Global Cardiovascular POCT Sales Volume by Application
        4.3.1 Global Cardiovascular POCT Sales Volume by Application (2020 VS 2024 VS 2031)
        4.3.2 Global Cardiovascular POCT Sales Volume, by Application (2020-2031)
        4.3.3 Global Cardiovascular POCT Sales Volume, by Application (%) (2020-2031)
    4.4 Global Cardiovascular POCT Average Price by Application (2020-2031)
5 Segmentation by Region
    5.1 Global Cardiovascular POCT Sales Value by Region
        5.1.1 Global Cardiovascular POCT Sales Value by Region: 2020 VS 2024 VS 2031
        5.1.2 Global Cardiovascular POCT Sales Value by Region (2020-2025)
        5.1.3 Global Cardiovascular POCT Sales Value by Region (2026-2031)
        5.1.4 Global Cardiovascular POCT Sales Value by Region (%), (2020-2031)
    5.2 Global Cardiovascular POCT Sales Volume by Region
        5.2.1 Global Cardiovascular POCT Sales Volume by Region: 2020 VS 2024 VS 2031
        5.2.2 Global Cardiovascular POCT Sales Volume by Region (2020-2025)
        5.2.3 Global Cardiovascular POCT Sales Volume by Region (2026-2031)
        5.2.4 Global Cardiovascular POCT Sales Volume by Region (%), (2020-2031)
    5.3 Global Cardiovascular POCT Average Price by Region (2020-2031)
    5.4 North America
        5.4.1 North America Cardiovascular POCT Sales Value, 2020-2031
        5.4.2 North America Cardiovascular POCT Sales Value by Country (%), 2024 VS 2031
    5.5 Europe
        5.5.1 Europe Cardiovascular POCT Sales Value, 2020-2031
        5.5.2 Europe Cardiovascular POCT Sales Value by Country (%), 2024 VS 2031
    5.6 Asia Pacific
        5.6.1 Asia Pacific Cardiovascular POCT Sales Value, 2020-2031
        5.6.2 Asia Pacific Cardiovascular POCT Sales Value by Region (%), 2024 VS 2031
    5.7 South America
        5.7.1 South America Cardiovascular POCT Sales Value, 2020-2031
        5.7.2 South America Cardiovascular POCT Sales Value by Country (%), 2024 VS 2031
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Cardiovascular POCT Sales Value, 2020-2031
        5.8.2 Middle East & Africa Cardiovascular POCT Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Cardiovascular POCT Sales Value Growth Trends, 2020 VS 2024 VS 2031
    6.2 Key Countries/Regions Cardiovascular POCT Sales Value
        6.2.1 Key Countries/Regions Cardiovascular POCT Sales Value, 2020-2031
        6.2.2 Key Countries/Regions Cardiovascular POCT Sales Volume, 2020-2031
    6.3 United States
        6.3.1 United States Cardiovascular POCT Sales Value, 2020-2031
        6.3.2 United States Cardiovascular POCT Sales Value by Type (%), 2024 VS 2031
        6.3.3 United States Cardiovascular POCT Sales Value by Application, 2024 VS 2031
    6.4 Europe
        6.4.1 Europe Cardiovascular POCT Sales Value, 2020-2031
        6.4.2 Europe Cardiovascular POCT Sales Value by Type (%), 2024 VS 2031
        6.4.3 Europe Cardiovascular POCT Sales Value by Application, 2024 VS 2031
    6.5 China
        6.5.1 China Cardiovascular POCT Sales Value, 2020-2031
        6.5.2 China Cardiovascular POCT Sales Value by Type (%), 2024 VS 2031
        6.5.3 China Cardiovascular POCT Sales Value by Application, 2024 VS 2031
    6.6 Japan
        6.6.1 Japan Cardiovascular POCT Sales Value, 2020-2031
        6.6.2 Japan Cardiovascular POCT Sales Value by Type (%), 2024 VS 2031
        6.6.3 Japan Cardiovascular POCT Sales Value by Application, 2024 VS 2031
    6.7 South Korea
        6.7.1 South Korea Cardiovascular POCT Sales Value, 2020-2031
        6.7.2 South Korea Cardiovascular POCT Sales Value by Type (%), 2024 VS 2031
        6.7.3 South Korea Cardiovascular POCT Sales Value by Application, 2024 VS 2031
    6.8 Southeast Asia
        6.8.1 Southeast Asia Cardiovascular POCT Sales Value, 2020-2031
        6.8.2 Southeast Asia Cardiovascular POCT Sales Value by Type (%), 2024 VS 2031
        6.8.3 Southeast Asia Cardiovascular POCT Sales Value by Application, 2024 VS 2031
    6.9 India
        6.9.1 India Cardiovascular POCT Sales Value, 2020-2031
        6.9.2 India Cardiovascular POCT Sales Value by Type (%), 2024 VS 2031
        6.9.3 India Cardiovascular POCT Sales Value by Application, 2024 VS 2031
7 Company Profiles
    7.1 Roche
        7.1.1 Roche Company Information
        7.1.2 Roche Introduction and Business Overview
        7.1.3 Roche Cardiovascular POCT Sales, Revenue, Price and Gross Margin (2020-2025)
        7.1.4 Roche Cardiovascular POCT Product Offerings
        7.1.5 Roche Recent Development
    7.2 Abbott
        7.2.1 Abbott Company Information
        7.2.2 Abbott Introduction and Business Overview
        7.2.3 Abbott Cardiovascular POCT Sales, Revenue, Price and Gross Margin (2020-2025)
        7.2.4 Abbott Cardiovascular POCT Product Offerings
        7.2.5 Abbott Recent Development
    7.3 BioMerieux
        7.3.1 BioMerieux Company Information
        7.3.2 BioMerieux Introduction and Business Overview
        7.3.3 BioMerieux Cardiovascular POCT Sales, Revenue, Price and Gross Margin (2020-2025)
        7.3.4 BioMerieux Cardiovascular POCT Product Offerings
        7.3.5 BioMerieux Recent Development
    7.4 Wuhan Easy Diagnosis Biomedicine Co.,ltd.
        7.4.1 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Company Information
        7.4.2 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Introduction and Business Overview
        7.4.3 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Cardiovascular POCT Sales, Revenue, Price and Gross Margin (2020-2025)
        7.4.4 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Cardiovascular POCT Product Offerings
        7.4.5 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Recent Development
    7.5 Guangzhou Wondfo Biotech Co.,Ltd.
        7.5.1 Guangzhou Wondfo Biotech Co.,Ltd. Company Information
        7.5.2 Guangzhou Wondfo Biotech Co.,Ltd. Introduction and Business Overview
        7.5.3 Guangzhou Wondfo Biotech Co.,Ltd. Cardiovascular POCT Sales, Revenue, Price and Gross Margin (2020-2025)
        7.5.4 Guangzhou Wondfo Biotech Co.,Ltd. Cardiovascular POCT Product Offerings
        7.5.5 Guangzhou Wondfo Biotech Co.,Ltd. Recent Development
    7.6 Getein Biotech, Inc.
        7.6.1 Getein Biotech, Inc. Company Information
        7.6.2 Getein Biotech, Inc. Introduction and Business Overview
        7.6.3 Getein Biotech, Inc. Cardiovascular POCT Sales, Revenue, Price and Gross Margin (2020-2025)
        7.6.4 Getein Biotech, Inc. Cardiovascular POCT Product Offerings
        7.6.5 Getein Biotech, Inc. Recent Development
    7.7 Sinocare Inc
        7.7.1 Sinocare Inc Company Information
        7.7.2 Sinocare Inc Introduction and Business Overview
        7.7.3 Sinocare Inc Cardiovascular POCT Sales, Revenue, Price and Gross Margin (2020-2025)
        7.7.4 Sinocare Inc Cardiovascular POCT Product Offerings
        7.7.5 Sinocare Inc Recent Development
    7.8 Relia Bioengineering Co., Ltd
        7.8.1 Relia Bioengineering Co., Ltd Company Information
        7.8.2 Relia Bioengineering Co., Ltd Introduction and Business Overview
        7.8.3 Relia Bioengineering Co., Ltd Cardiovascular POCT Sales, Revenue, Price and Gross Margin (2020-2025)
        7.8.4 Relia Bioengineering Co., Ltd Cardiovascular POCT Product Offerings
        7.8.5 Relia Bioengineering Co., Ltd Recent Development
    7.9 Beijing Hotgen Biotech Co.,ltd.
        7.9.1 Beijing Hotgen Biotech Co.,ltd. Company Information
        7.9.2 Beijing Hotgen Biotech Co.,ltd. Introduction and Business Overview
        7.9.3 Beijing Hotgen Biotech Co.,ltd. Cardiovascular POCT Sales, Revenue, Price and Gross Margin (2020-2025)
        7.9.4 Beijing Hotgen Biotech Co.,ltd. Cardiovascular POCT Product Offerings
        7.9.5 Beijing Hotgen Biotech Co.,ltd. Recent Development
    7.10 Assure Tech (Hangzhou) Co.,Ltd.
        7.10.1 Assure Tech (Hangzhou) Co.,Ltd. Company Information
        7.10.2 Assure Tech (Hangzhou) Co.,Ltd. Introduction and Business Overview
        7.10.3 Assure Tech (Hangzhou) Co.,Ltd. Cardiovascular POCT Sales, Revenue, Price and Gross Margin (2020-2025)
        7.10.4 Assure Tech (Hangzhou) Co.,Ltd. Cardiovascular POCT Product Offerings
        7.10.5 Assure Tech (Hangzhou) Co.,Ltd. Recent Development
    7.11 Nanjing Vazyme Biotech Co.,Ltd.
        7.11.1 Nanjing Vazyme Biotech Co.,Ltd. Company Information
        7.11.2 Nanjing Vazyme Biotech Co.,Ltd. Introduction and Business Overview
        7.11.3 Nanjing Vazyme Biotech Co.,Ltd. Cardiovascular POCT Sales, Revenue, Price and Gross Margin (2020-2025)
        7.11.4 Nanjing Vazyme Biotech Co.,Ltd. Cardiovascular POCT Product Offerings
        7.11.5 Nanjing Vazyme Biotech Co.,Ltd. Recent Development
    7.12 Siemens Healthineers
        7.12.1 Siemens Healthineers Company Information
        7.12.2 Siemens Healthineers Introduction and Business Overview
        7.12.3 Siemens Healthineers Cardiovascular POCT Sales, Revenue, Price and Gross Margin (2020-2025)
        7.12.4 Siemens Healthineers Cardiovascular POCT Product Offerings
        7.12.5 Siemens Healthineers Recent Development
    7.13 Danaher
        7.13.1 Danaher Company Information
        7.13.2 Danaher Introduction and Business Overview
        7.13.3 Danaher Cardiovascular POCT Sales, Revenue, Price and Gross Margin (2020-2025)
        7.13.4 Danaher Cardiovascular POCT Product Offerings
        7.13.5 Danaher Recent Development
    7.14 Sansure Biotech Inc.
        7.14.1 Sansure Biotech Inc. Company Information
        7.14.2 Sansure Biotech Inc. Introduction and Business Overview
        7.14.3 Sansure Biotech Inc. Cardiovascular POCT Sales, Revenue, Price and Gross Margin (2020-2025)
        7.14.4 Sansure Biotech Inc. Cardiovascular POCT Product Offerings
        7.14.5 Sansure Biotech Inc. Recent Development
8 Industry Chain Analysis
    8.1 Cardiovascular POCT Industrial Chain
    8.2 Cardiovascular POCT Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Cardiovascular POCT Sales Model
        8.5.2 Sales Channel
        8.5.3 Cardiovascular POCT Distributors
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
            10.1.1.1 Research Programs/Design
            10.1.1.2 Market Size Estimation
            10.1.1.3 Market Breakdown and Data Triangulation
        10.1.2 Data Source
            10.1.2.1 Secondary Sources
            10.1.2.2 Primary Sources
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Cardiovascular POCT Market Trends
 Table 2. Cardiovascular POCT Market Drivers & Opportunity
 Table 3. Cardiovascular POCT Market Challenges
 Table 4. Cardiovascular POCT Market Restraints
 Table 5. Global Cardiovascular POCT Revenue by Company (2020-2025) & (US$ Million)
 Table 6. Global Cardiovascular POCT Revenue Market Share by Company (2020-2025)
 Table 7. Global Cardiovascular POCT Sales Volume by Company (2020-2025) & (K Units)
 Table 8. Global Cardiovascular POCT Sales Volume Market Share by Company (2020-2025)
 Table 9. Global Market Cardiovascular POCT Price by Company (2020-2025) & (US$/Unit)
 Table 10. Key Manufacturers Cardiovascular POCT Manufacturing Base and Headquarters
 Table 11. Key Manufacturers Cardiovascular POCT Product Type
 Table 12. Key Manufacturers Time to Begin Mass Production of Cardiovascular POCT
 Table 13. Global Cardiovascular POCT Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiovascular POCT as of 2024)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Cardiovascular POCT Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Cardiovascular POCT Sales Value by Type (2020-2025) & (US$ Million)
 Table 18. Global Cardiovascular POCT Sales Value by Type (2026-2031) & (US$ Million)
 Table 19. Global Cardiovascular POCT Sales Market Share in Value by Type (2020-2025)
 Table 20. Global Cardiovascular POCT Sales Market Share in Value by Type (2026-2031)
 Table 21. Global Cardiovascular POCT Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
 Table 22. Global Cardiovascular POCT Sales Volume by Type (2020-2025) & (K Units)
 Table 23. Global Cardiovascular POCT Sales Volume by Type (2026-2031) & (K Units)
 Table 24. Global Cardiovascular POCT Sales Market Share in Volume by Type (2020-2025)
 Table 25. Global Cardiovascular POCT Sales Market Share in Volume by Type (2026-2031)
 Table 26. Global Cardiovascular POCT Price by Type (2020-2025) & (US$/Unit)
 Table 27. Global Cardiovascular POCT Price by Type (2026-2031) & (US$/Unit)
 Table 28. Global Cardiovascular POCT Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
 Table 29. Global Cardiovascular POCT Sales Value by Application (2020-2025) & (US$ Million)
 Table 30. Global Cardiovascular POCT Sales Value by Application (2026-2031) & (US$ Million)
 Table 31. Global Cardiovascular POCT Sales Market Share in Value by Application (2020-2025)
 Table 32. Global Cardiovascular POCT Sales Market Share in Value by Application (2026-2031)
 Table 33. Global Cardiovascular POCT Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
 Table 34. Global Cardiovascular POCT Sales Volume by Application (2020-2025) & (K Units)
 Table 35. Global Cardiovascular POCT Sales Volume by Application (2026-2031) & (K Units)
 Table 36. Global Cardiovascular POCT Sales Market Share in Volume by Application (2020-2025)
 Table 37. Global Cardiovascular POCT Sales Market Share in Volume by Application (2026-2031)
 Table 38. Global Cardiovascular POCT Price by Application (2020-2025) & (US$/Unit)
 Table 39. Global Cardiovascular POCT Price by Application (2026-2031) & (US$/Unit)
 Table 40. Global Cardiovascular POCT Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
 Table 41. Global Cardiovascular POCT Sales Value by Region (2020-2025) & (US$ Million)
 Table 42. Global Cardiovascular POCT Sales Value by Region (2026-2031) & (US$ Million)
 Table 43. Global Cardiovascular POCT Sales Value by Region (2020-2025) & (%)
 Table 44. Global Cardiovascular POCT Sales Value by Region (2026-2031) & (%)
 Table 45. Global Cardiovascular POCT Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
 Table 46. Global Cardiovascular POCT Sales Volume by Region (2020-2025) & (K Units)
 Table 47. Global Cardiovascular POCT Sales Volume by Region (2026-2031) & (K Units)
 Table 48. Global Cardiovascular POCT Sales Volume by Region (2020-2025) & (%)
 Table 49. Global Cardiovascular POCT Sales Volume by Region (2026-2031) & (%)
 Table 50. Global Cardiovascular POCT Average Price by Region (2020-2025) & (US$/Unit)
 Table 51. Global Cardiovascular POCT Average Price by Region (2026-2031) & (US$/Unit)
 Table 52. Key Countries/Regions Cardiovascular POCT Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
 Table 53. Key Countries/Regions Cardiovascular POCT Sales Value, (2020-2025) & (US$ Million)
 Table 54. Key Countries/Regions Cardiovascular POCT Sales Value, (2026-2031) & (US$ Million)
 Table 55. Key Countries/Regions Cardiovascular POCT Sales Volume, (2020-2025) & (K Units)
 Table 56. Key Countries/Regions Cardiovascular POCT Sales Volume, (2026-2031) & (K Units)
 Table 57. Roche Company Information
 Table 58. Roche Introduction and Business Overview
 Table 59. Roche Cardiovascular POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 60. Roche Cardiovascular POCT Product Offerings
 Table 61. Roche Recent Development
 Table 62. Abbott Company Information
 Table 63. Abbott Introduction and Business Overview
 Table 64. Abbott Cardiovascular POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 65. Abbott Cardiovascular POCT Product Offerings
 Table 66. Abbott Recent Development
 Table 67. BioMerieux Company Information
 Table 68. BioMerieux Introduction and Business Overview
 Table 69. BioMerieux Cardiovascular POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 70. BioMerieux Cardiovascular POCT Product Offerings
 Table 71. BioMerieux Recent Development
 Table 72. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Company Information
 Table 73. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Introduction and Business Overview
 Table 74. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Cardiovascular POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 75. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Cardiovascular POCT Product Offerings
 Table 76. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Recent Development
 Table 77. Guangzhou Wondfo Biotech Co.,Ltd. Company Information
 Table 78. Guangzhou Wondfo Biotech Co.,Ltd. Introduction and Business Overview
 Table 79. Guangzhou Wondfo Biotech Co.,Ltd. Cardiovascular POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 80. Guangzhou Wondfo Biotech Co.,Ltd. Cardiovascular POCT Product Offerings
 Table 81. Guangzhou Wondfo Biotech Co.,Ltd. Recent Development
 Table 82. Getein Biotech, Inc. Company Information
 Table 83. Getein Biotech, Inc. Introduction and Business Overview
 Table 84. Getein Biotech, Inc. Cardiovascular POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 85. Getein Biotech, Inc. Cardiovascular POCT Product Offerings
 Table 86. Getein Biotech, Inc. Recent Development
 Table 87. Sinocare Inc Company Information
 Table 88. Sinocare Inc Introduction and Business Overview
 Table 89. Sinocare Inc Cardiovascular POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Sinocare Inc Cardiovascular POCT Product Offerings
 Table 91. Sinocare Inc Recent Development
 Table 92. Relia Bioengineering Co., Ltd Company Information
 Table 93. Relia Bioengineering Co., Ltd Introduction and Business Overview
 Table 94. Relia Bioengineering Co., Ltd Cardiovascular POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 95. Relia Bioengineering Co., Ltd Cardiovascular POCT Product Offerings
 Table 96. Relia Bioengineering Co., Ltd Recent Development
 Table 97. Beijing Hotgen Biotech Co.,ltd. Company Information
 Table 98. Beijing Hotgen Biotech Co.,ltd. Introduction and Business Overview
 Table 99. Beijing Hotgen Biotech Co.,ltd. Cardiovascular POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 100. Beijing Hotgen Biotech Co.,ltd. Cardiovascular POCT Product Offerings
 Table 101. Beijing Hotgen Biotech Co.,ltd. Recent Development
 Table 102. Assure Tech (Hangzhou) Co.,Ltd. Company Information
 Table 103. Assure Tech (Hangzhou) Co.,Ltd. Introduction and Business Overview
 Table 104. Assure Tech (Hangzhou) Co.,Ltd. Cardiovascular POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 105. Assure Tech (Hangzhou) Co.,Ltd. Cardiovascular POCT Product Offerings
 Table 106. Assure Tech (Hangzhou) Co.,Ltd. Recent Development
 Table 107. Nanjing Vazyme Biotech Co.,Ltd. Company Information
 Table 108. Nanjing Vazyme Biotech Co.,Ltd. Introduction and Business Overview
 Table 109. Nanjing Vazyme Biotech Co.,Ltd. Cardiovascular POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 110. Nanjing Vazyme Biotech Co.,Ltd. Cardiovascular POCT Product Offerings
 Table 111. Nanjing Vazyme Biotech Co.,Ltd. Recent Development
 Table 112. Siemens Healthineers Company Information
 Table 113. Siemens Healthineers Introduction and Business Overview
 Table 114. Siemens Healthineers Cardiovascular POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 115. Siemens Healthineers Cardiovascular POCT Product Offerings
 Table 116. Siemens Healthineers Recent Development
 Table 117. Danaher Company Information
 Table 118. Danaher Introduction and Business Overview
 Table 119. Danaher Cardiovascular POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 120. Danaher Cardiovascular POCT Product Offerings
 Table 121. Danaher Recent Development
 Table 122. Sansure Biotech Inc. Company Information
 Table 123. Sansure Biotech Inc. Introduction and Business Overview
 Table 124. Sansure Biotech Inc. Cardiovascular POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 125. Sansure Biotech Inc. Cardiovascular POCT Product Offerings
 Table 126. Sansure Biotech Inc. Recent Development
 Table 127. Key Raw Materials Lists
 Table 128. Raw Materials Key Suppliers Lists
 Table 129. Cardiovascular POCT Downstream Customers
 Table 130. Cardiovascular POCT Distributors List
 Table 131. Research Programs/Design for This Report
 Table 132. Key Data Information from Secondary Sources
 Table 133. Key Data Information from Primary Sources


List of Figures
 Figure 1. Cardiovascular POCT Product Picture
 Figure 2. Global Cardiovascular POCT Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Global Cardiovascular POCT Sales Value (2020-2031) & (US$ Million)
 Figure 4. Global Cardiovascular POCT Sales Volume (2020-2031) & (K Units)
 Figure 5. Global Cardiovascular POCT Sales Price (2020-2031) & (US$/Unit)
 Figure 6. Cardiovascular POCT Report Years Considered
 Figure 7. Global Cardiovascular POCT Players Revenue Ranking (2024) & (US$ Million)
 Figure 8. Global Cardiovascular POCT Players Sales Volume Ranking (2024) & (K Units)
 Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Cardiovascular POCT Revenue in 2024
 Figure 10. Cardiovascular POCT Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 11. Based on Immunochromatography Picture
 Figure 12. Based on Chemiluminescence Technology Picture
 Figure 13. Based on Biosensor Picture
 Figure 14. Based on Colloidal Gold Picture
 Figure 15. Others Picture
 Figure 16. Global Cardiovascular POCT Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 17. Global Cardiovascular POCT Sales Value Market Share by Type, 2024 & 2031
 Figure 18. Global Cardiovascular POCT Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
 Figure 19. Global Cardiovascular POCT Sales Volume Market Share by Type, 2024 & 2031
 Figure 20. Global Cardiovascular POCT Price by Type (2020-2031) & (US$/Unit)
 Figure 21. Product Picture of Hospital
 Figure 22. Product Picture of lndependent Testing Organization
 Figure 23. Global Cardiovascular POCT Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 24. Global Cardiovascular POCT Sales Value Market Share by Application, 2024 & 2031
 Figure 25. Global Cardiovascular POCT Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
 Figure 26. Global Cardiovascular POCT Sales Volume Market Share by Application, 2024 & 2031
 Figure 27. Global Cardiovascular POCT Price by Application (2020-2031) & (US$/Unit)
 Figure 28. North America Cardiovascular POCT Sales Value (2020-2031) & (US$ Million)
 Figure 29. North America Cardiovascular POCT Sales Value by Country (%), 2024 VS 2031
 Figure 30. Europe Cardiovascular POCT Sales Value, (2020-2031) & (US$ Million)
 Figure 31. Europe Cardiovascular POCT Sales Value by Country (%), 2024 VS 2031
 Figure 32. Asia Pacific Cardiovascular POCT Sales Value, (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Cardiovascular POCT Sales Value by Region (%), 2024 VS 2031
 Figure 34. South America Cardiovascular POCT Sales Value, (2020-2031) & (US$ Million)
 Figure 35. South America Cardiovascular POCT Sales Value by Country (%), 2024 VS 2031
 Figure 36. Middle East & Africa Cardiovascular POCT Sales Value, (2020-2031) & (US$ Million)
 Figure 37. Middle East & Africa Cardiovascular POCT Sales Value by Country (%), 2024 VS 2031
 Figure 38. Key Countries/Regions Cardiovascular POCT Sales Value (%), (2020-2031)
 Figure 39. Key Countries/Regions Cardiovascular POCT Sales Volume (%), (2020-2031)
 Figure 40. United States Cardiovascular POCT Sales Value, (2020-2031) & (US$ Million)
 Figure 41. United States Cardiovascular POCT Sales Value by Type (%), 2024 VS 2031
 Figure 42. United States Cardiovascular POCT Sales Value by Application (%), 2024 VS 2031
 Figure 43. Europe Cardiovascular POCT Sales Value, (2020-2031) & (US$ Million)
 Figure 44. Europe Cardiovascular POCT Sales Value by Type (%), 2024 VS 2031
 Figure 45. Europe Cardiovascular POCT Sales Value by Application (%), 2024 VS 2031
 Figure 46. China Cardiovascular POCT Sales Value, (2020-2031) & (US$ Million)
 Figure 47. China Cardiovascular POCT Sales Value by Type (%), 2024 VS 2031
 Figure 48. China Cardiovascular POCT Sales Value by Application (%), 2024 VS 2031
 Figure 49. Japan Cardiovascular POCT Sales Value, (2020-2031) & (US$ Million)
 Figure 50. Japan Cardiovascular POCT Sales Value by Type (%), 2024 VS 2031
 Figure 51. Japan Cardiovascular POCT Sales Value by Application (%), 2024 VS 2031
 Figure 52. South Korea Cardiovascular POCT Sales Value, (2020-2031) & (US$ Million)
 Figure 53. South Korea Cardiovascular POCT Sales Value by Type (%), 2024 VS 2031
 Figure 54. South Korea Cardiovascular POCT Sales Value by Application (%), 2024 VS 2031
 Figure 55. Southeast Asia Cardiovascular POCT Sales Value, (2020-2031) & (US$ Million)
 Figure 56. Southeast Asia Cardiovascular POCT Sales Value by Type (%), 2024 VS 2031
 Figure 57. Southeast Asia Cardiovascular POCT Sales Value by Application (%), 2024 VS 2031
 Figure 58. India Cardiovascular POCT Sales Value, (2020-2031) & (US$ Million)
 Figure 59. India Cardiovascular POCT Sales Value by Type (%), 2024 VS 2031
 Figure 60. India Cardiovascular POCT Sales Value by Application (%), 2024 VS 2031
 Figure 61. Cardiovascular POCT Industrial Chain
 Figure 62. Cardiovascular POCT Manufacturing Cost Structure
 Figure 63. Channels of Distribution (Direct Sales, and Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed

Description 

The global market for Cardiovascular POCT was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Cardiovascular POCT, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Cardiovascular POCT by region & country, by Type, and by Application.

The Cardiovascular POCT market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiovascular POCT.

Market Segmentation
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Cardiovascular POCT manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Cardiovascular POCT in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Cardiovascular POCT in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
den_biaoTiZhungShi

Related Reports

Cardiovascular POCT- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Medical Devices & Consumables

Published: 2025-02-14

Pages: 117 Pages

Report ld: 3869362

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

CHOOSE LICENSE TYPE
tip

USD 3950.00

tip

USD 5925.00

tip

USD 7900.00

Add to Cart

Add to Cart

Buy Now

Buy Now

Have a question?
SIMON LEE

English

English

SIMON LEE

+1-62 6295 2442

Online

JOHN WANG

English

English

JOHN WANG

+41 765 899 438

Offline

HITESH

English

English

HITESH

+91-86 6998 6909

Offline

TANG XIN

Japanese

Japanese

TANG XIN

+81-90 3800 9273

Offline

SUNG-BIN YOON

Korean

Korean

SUNG-BIN YOON

+82-2883 1278

Offline

YUJIE TIAN

English

English

YUJIE TIAN

+86-135-2215-3954

Offline

DAMON

Chinese

Chinese

DAMON

+86-133 1872 9947

Offline

General Email:
global@qyresearch.com
WHAT QYRESEARCH OFFER?
Competition

Competition

Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.

Industry Analysis

Industry Analysis

Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.

Market Size

Market Size

Capacity, production, sales, revenue, price, cost etc.

Customized Information

Customized Information

We can offer customized survey and information to meet ourclient's need.

INTEREST IN THIS REPORT?

Get A Free Sample >>
WHY QYR?
  • Fastest report delivery service

    Fastest report delivery service

  • More than 19 years of vast experience

    More than 19 years of vast experience

  • Operation for 24 * 7 & 365 days

    Operation for 24 * 7 & 365 days

  • In-depth and comprehensive analysis

    In-depth and comprehensive analysis

  • Professional and timely after-sales service

    Professional and timely after-sales service

  • Owns large database

    Owns large database

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now